Commerzbank Aktiengesellschaft Takeda Pharmaceutical CO LTD Transaction History

Commerzbank Aktiengesellschaft

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 29, 2020	SELL	$13.02 - $20.31 $1.91 Million - $2.97 Million	-146,432 Closed	0 $0
Q4 2019 Oct 03, 2024	BUY	$16.88 - $20.83 $2.47 Million - $3.05 Million	146,432 New	146,432 $2.89 Million
Q4 2019 Jan 17, 2020	SELL	$16.88 - $20.83 $34,739 - $42,868	-2,058 Reduced 1.39%	146,432 $2.89 Million
Q3 2019 Oct 03, 2024	BUY	$16.15 - $17.99 $2.4 Million - $2.67 Million	148,490 New	148,490 $2.55 Million
Q3 2019 Oct 17, 2019	SELL	$16.15 - $17.99 $2,357 - $2,626	-146 Reduced 0.1%	148,490 $2.55 Million
Q2 2019 Oct 03, 2024	BUY	$16.58 - $20.49 $2.46 Million - $3.05 Million	148,636 New	148,636 $2.63 Million
Q2 2019 Jul 23, 2019	SELL	$16.58 - $20.49 $31,700 - $39,176	-1,912 Reduced 1.27%	148,636 $2.63 Million
Q1 2019 Oct 03, 2024	BUY	$16.7 - $21.52 $2.51 Million - $3.24 Million	150,548 New	150,548 $3.07 Million
Q1 2019 May 13, 2019	BUY	$16.7 - $21.52 $2.51 Million - $3.24 Million	150,548 New	150,548 $3.07 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.